Literature DB >> 8314680

First experience in application of heparin-induced extracorporeal LDL precipitation (H.E.L.P.) in acute thromboembolic stroke.

H Lechner1, M Walzl, B Walzl, G Kleinert.   

Abstract

Heparin-induced Extracorporeal LDL < total cholesterol, triglycerides, fibrinogen > Precipitation (H.E.L.P.) was applied in cases of acute thromboembolic stroke within 48 to 96 hours after onset. 42 patients had been randomized for the trial. In Group A 12 patients underwent a single H.E.L.P. application, while remaining 10 patients formed a control group. In group B 10 patients had 10 H.E.L.P. applications, the other 10 patients firmed as controls. Results of group A: 4 days after H.E.L.P. an improvement in the Mathew Scale and in the Mini Mental State Examination could be obtained (p < 0.05 each). 10 days after H.E.L.P. all the tests showed significant changes (p < 0.05 in the Mathew Scale and in the Mini Mental State Examination and p < 0.01 in the Activities-of-Daily-Living Score). Relatet to the controls there appeared a statistically significant difference 4 days after H.E.L.P. in the Mini Mental State Examination and in the Activities-of-Daily-Living Score (p < 0.05 each). At day 10 all the tests showed a difference to the controls (p < 0.05 in the Mathew Scale and p < 0.01 in the other tests). Results of group B 10: One day after 1st H.E.L.P. a statistically significant difference could be observed in all the tests (p < 0.05 in the Mathew Scale and the Mini Mental State Examination and p < 0.01 in the Activities-of-Daily-Living Score). At that time even a difference to the controls became visible (p < 0.05 in the Mathew scale, p < 0.01 in the other tests).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8314680     DOI: 10.1007/bf02335667

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  9 in total

1.  Enhanced erythrocyte aggregability in occlusive cerebrovascular disease.

Authors:  N Tanahashi; F Gotoh; M Tomita; T Shinohara; Y Terayama; B Mihara; K Ohta; M Nara
Journal:  Stroke       Date:  1989-09       Impact factor: 7.914

2.  High blood viscosity syndrome in cerebral infarction.

Authors:  E O Ott; H Lechner; A Aranibar
Journal:  Stroke       Date:  1974 May-Jun       Impact factor: 7.914

3.  Hemorheologic parameters in correlation to extracranial carotid artery disease in patients with acute cerebrovascular disorders.

Authors:  H Lechner; K Niederkorn; H Suzuki
Journal:  Eur Neurol       Date:  1987       Impact factor: 1.710

4.  Whole blood viscosity parameters and cerebral blood flow.

Authors:  J Grotta; R Ackerman; J Correia; G Fallick; J Chang
Journal:  Stroke       Date:  1982 May-Jun       Impact factor: 7.914

5.  The HELP system: an efficient and safe method of plasma therapy in the treatment of severe hypercholesterolemia.

Authors:  D Seidel
Journal:  Ther Umsch       Date:  1990-06

6.  Age-specific norms for the Mini-Mental State Exam.

Authors:  M L Bleecker; K Bolla-Wilson; C Kawas; J Agnew
Journal:  Neurology       Date:  1988-10       Impact factor: 9.910

7.  Pentoxifylline in acute nonhemorrhagic stroke. A randomized, placebo-controlled double-blind trial.

Authors:  C Y Hsu; J W Norris; E L Hogan; P Bladin; H B Dinsdale; F M Yatsu; M P Earnest; P Scheinberg; L R Caplan; H R Karp
Journal:  Stroke       Date:  1988-06       Impact factor: 7.914

8.  Fibrinogen as a risk factor for stroke and myocardial infarction.

Authors:  L Wilhelmsen; K Svärdsudd; K Korsan-Bengtsen; B Larsson; L Welin; G Tibblin
Journal:  N Engl J Med       Date:  1984-08-23       Impact factor: 91.245

9.  Evaluation of the North Carolina Stroke Care Program.

Authors:  M B Dignan; G Howard; J F Toole; C Becker; K R McLeroy
Journal:  Stroke       Date:  1986 May-Jun       Impact factor: 7.914

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.